- $2.74bn
- $2.66bn
- $164.39m
- 54
- 22
- 95
- 58
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 23.2 | 164 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 7.29 | 49.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15 | 14.3 | 17.2 | 25.7 | 155 |
Operating Profit | -15 | -14.3 | -17.2 | -2.59 | 9.29 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.2 | -14.6 | -14.8 | 5.25 | -2.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.2 | -14.6 | -14.8 | 5.25 | -3.31 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.2 | -14.6 | -14.8 | 5.25 | -3.31 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.2 | -14.6 | -14.8 | 5.25 | -3.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.103 | -0.08 | -0.071 | -0.035 | -0.01 |